# Adjunctive Use of Celecoxib in the Treatment of Bipolar Postpartum Depression

> **NCT02726659** · PHASE3 · TERMINATED · sponsor: **London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's** · enrollment: 1 (actual)

## Conditions studied

- Bipolar Disorder
- Postpartum Depression

## Interventions

- **DRUG:** Celecoxib
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02726659
- **Lead sponsor:** London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2016-05
- **Primary completion:** 2019-01-16
- **Final completion:** 2019-01-16
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** Difficulty recruiting participants because principal investigator noticed that the participants in the population were responding well to low doses of mood stabilizers and therefor would not be recruited into the study.
- **Last updated:** 2022-01-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02726659

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02726659, "Adjunctive Use of Celecoxib in the Treatment of Bipolar Postpartum Depression". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT02726659. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*